The FTC asks for more info about Pfizer-Allergan deal; the FDA loosens guidelines for abortion-inducing drug; startup to deliver Truvada through an app
Viscira, a digital marketing agency, works with GlaxoSmithKline, Merck, and Genentech, among other life-sciences companies.
Here's my biggest gripe: Innovation teams should be driving innovation for their particular business, not just for marketing and communications.
Perfectionists in the world of pharma marketing can no longer rely on the status quo, given current threats to traditional commercial models and the rise of digital HCP engagement.
The agency announced a partnership with Vencore Health Analytics to help pair rare disease patients with drugmakers.
The Silicon Valley gadget guru who helped define the beyond-the-pill era will talk about embedding nontraditional capabilities into biopharma business models.
They will attempt to develop a new industry standard for digital advertising viewability, a much debated topic that has vexed the broader advertising industry.
Part of LinkedIn's appeal lies in the high level of engagement of its members and the potential for precise targeting of content and talent searches.
Fitbit faces allegations of inaccurate heart monitoring; Viiv Healthcare to collaborate with Janssen; Guardant Health raises funding for its cancer blood tests
Here are the 40 executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.
An initial list of consumer health tech deemed essential by MIT and Harvard doctors is short on pharma-backed apps or services.
The agency will team up with Tsinghua Institute of Health Communication on study on how consumers interact with healthcare content.
A nonprofit institute will soon start producing consumer reviews of digital health tools that have been vetted by Harvard clinicians.
The company "embraces" adverse-event reporting and knows not to expect monetary ROI from unbranded initiatives, says its US-based social media lead.
The deal combines two of Merck's wholly owned subsidiaries.
Part of the challenge for drugmakers, medical-device makers and healthcare providers is finding the right digital talent and advocating for cultural changes within their organizations.
Microsoft's second-generation fitness tracker comes outfitted with new sensors aimed at better capturing user activity.
The drugmaker launched its first YouTube channel as it kicked off the campaign.
Teva acquires sensor-based inhaler; EU conditionally approves Amgen's cancer drug, Blincyto; Novartis CEO says targeted therapies may reduce unnecessary US healthcare spending
In order to reach consumers, hospitals must rethink their old ways of marketing outreach.
Proteus and Otsuka seek approval of "digital" drug; J&J moves its US media-buying business back to UM; FDA committee votes no on Purdue's new opioid
Excitement about wearables like the Apple Watch or Fitbit sometimes fuels unrealistic hype about healthcare marketing opportunities.
21st Century Cures legislation passes the House; Novartis's heart-failure drug may launch with "beyond the pill" services; Purdue and GSK are working on using Apple's ResearchKit; the FDA issues warning letter on co-pay card
Mobile app makers shared insights about how to improve people's health and change behavior at the Lions Health festival.
It's not always regulation or concerns about legal risks. Sometimes, a drugmaker's internal conservative culture is the biggest hurdle to overcome.
The effort is part of the consultancy's Startup Challenge that pairs health neophytes with mentors.
Medscape marked its 20th anniversary with a reunion this week that attracted staffers from the portal's earliest days.
Moore, a longtime Goodwill Ambassador for Unicef, talked with MM&M about how creativity can be used to improve public health.
The academic partnership builds on the company's 2014 collaboration with UCB on using sensors to gather biometric data about people with neurological disorders.
A timeline of important milestones in the era of patient engagement
Click here to learn about the Agency Issue.
- When it comes to professional ads, print makes its comeback
- Amgen takes issue with yet-to-be published multiple-myeloma drug report
- How Watson for Oncology is advancing cancer care
- Creative partners should push pharma clients to tell better stories
- Retaining talent: How pharma can compete with Google